Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation

J Neurol Sci. 2018 Jul 15:390:33-35. doi: 10.1016/j.jns.2018.04.002. Epub 2018 Apr 7.

Authors

Tamour Khan Tareen¹, Carlo Alberto Artusi², Federico Rodriguez-Porcel¹, Johnna L Devoto¹, Habibullah Sheikh¹, George T Mandybur³, Andrew P Duker¹, Alberto J Espay¹, Aristide Merola⁴

Affiliations

¹ Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA.
² Department of Neuroscience "Rita Levi Montalcini", University of Turin, via Cherasco 15, 10124 Torino, Italy.
³ Mayfield Clinic, Department of Neurosurgery, USA.
⁴ Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA. Electronic address: merolaae@ucmail.uc.edu.

PMID: 29801902
DOI: 10.1016/j.jns.2018.04.002

No abstract available

Publication types

Letter

MeSH terms

Affective Symptoms / etiology*
Affective Symptoms / physiopathology
Age Factors
Aged
Antiparkinson Agents / therapeutic use
Apathy* / drug effects
Apathy* / physiology
Deep Brain Stimulation / adverse effects*
Depression / etiology*
Depression / physiopathology
Dopamine Agonists / therapeutic use*
Female
Humans
Male
Middle Aged
Parkinson Disease / physiopathology
Parkinson Disease / psychology
Parkinson Disease / therapy*
Prevalence
Retrospective Studies

Substances

Antiparkinson Agents
Dopamine Agonists